External resources PMC: A three-phase framework for combining GLP-1 receptor agonists with intermittent fasting , National Library of Medicine STEP-1 trial: Once-weekly semaglutide in adults with overweight or obesity , New England Journal of Medicine SURMOUNT-1 trial: Tirzepatide once weekly for the treatment of obesity , New England Journal of Medicine Weight management information and clinical resources , National Institute of Diabetes and Digestive and Kidney Diseases PubMed research database , National Library of Medicine For researchers serious about optimizing their GLP-1 protocols, SeekPeptides provides comprehensive protocol guides, dosing calculators, and a community of thousands navigating these exact questions
Led by IKIGAIs team of world-class experts, your personalised programme may include stem cell and exosome therapy, red light and ozone treatments, neurological optimisation, and in-depth diagnosticsall tailored to your unique biology
Effective: Clinical studies show that participants using GLP-1 medications lost 5-7 times more weight than with diet & exercise alone
Some research suggests it may help improve cholesterol, reduce insulin resistance and support weight management
The evaluating clinician determines whether this option is appropriate based on your individual health factors
There is no side effects